1-20 of 23
Hui Qiang Huang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combination of Mitoxantrone Hydrochloride Liposome with Cyclophosphamide, Vincristine and Prednisone (CMOP) in Treatment-Naïve Patients with Peripheral T-Cell Lymphoma: A Multicenter, Open-Label, Single-Arm, Phase Ib Clinical Trial

Hui-Qiang Huang, Gao Yan, Ming Jiang, Lihong Liu, Qing Xiao, Yufu Li, Hui Zhou, Jianfei Xue, Dong Wang, Dapeng Xie, Honglian Li, Peng Wang
Journal: Blood
Blood (2022) 140 (Supplement 1): 3762–3763.
https://doi.org/10.1182/blood-2022-163343
Published: 2022
Journal Articles

Glofitamab Monotherapy Demonstrates High Complete Response Rates and Manageable Safety in Chinese Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma and ≥2 Prior Therapies

Yu-Qin Song, Hui-Lai Zhang, Hui-Qiang Huang, Qing-Yuan Zhang, Hong-Mei Jing, Chao Wang, Chun Wu, Dong-Hang Li, Yu Dai, Kathryn Humphrey, Jun Zhu
Journal: Blood
Blood (2022) 140 (Supplement 1): 12050–12051.
https://doi.org/10.1182/blood-2022-157544
Published: 2022
Journal Articles

Prophylaxis of Neutropenia with Mecapegfilgrastim in Patients with Hematologic Malignancies

Hui-qiang Huang, Zengjun Li, Gang Cheng, Gao Yan, Zhihua Yao, Guifang Zhang, Xiaoguang Wang, Zhengxiang Han, Yong Chen, Haijiao Yan, Weie Zheng, Jun Yan, Yulan Gu, Zhangxia Ren, Rusen Zhao, Ningling Zhang, Jun Ma
Journal: Blood
Blood (2021) 138 (Supplement 1): 4569.
https://doi.org/10.1182/blood-2021-149884
Published: 2021
Journal Articles

Preliminary Results of a Phase II Study of Methotrexate in Combination with Ibrutinib and Temozolomide (MIT) in Newly Diagnosed Primary CNS Lymphoma

Xiaoxiao Wang, Yan Gao, Shanshan Yu, Bing Bai, Qiuxiang Ou, Liuqing Zhu, He Huang, Hui Zhou, Yang Shao, Linbo Cai, Hui-qiang Huang
Journal: Blood
Blood (2021) 138 (Supplement 1): 2481.
https://doi.org/10.1182/blood-2021-150658
Published: 2021
Journal Articles

A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphoma

Clinical Trials & Observations
Xiao-Peng Tian, Shu-Yun Ma, Ken H. Young, Choon Kiat Ong, Yan-Hui Liu, Zhi-Hua Li, Qiong-Li Zhai, Hui-Qiang Huang, Tong-Yu Lin, Zhi-Ming Li, Zhong-Jun Xia, Li-Ye Zhong, Hui-Lan Rao, Mei Li, Jun Cai, Yu-Chen Zhang, Fen Zhang, Ning Su, Peng-Fei Li, Feng Zhu, Zijun Y. Xu-Monette, Esther Kam Yin Wong, Jeslin Chian Hung Ha, Lay Poh Khoo, Le Ai, Run-Fen Cheng, Jing Quan Lim, Sanjay de Mel, Siok-Bian Ng, Soon Thye Lim, Qing-Qing Cai
Journal: Blood
Blood (2021) 138 (6): 452–463.
https://doi.org/10.1182/blood.2020010637
Published: 2021
Includes: Supplemental data
Journal Articles

Association of Circulating Tumor DNA from the Cerebrospinal Fluid with High-Risk CNS Involvement in Patients with Diffuse Large B-Cell Lymphoma

Xiaoxiao Wang, Yan Gao, MD PhD, Changguo Shan, Mingyao Lai, Haixia He, Bing Bai, Li-qin Ping, Qixiang Rong, Ruyu Ai, Lei Wen, Zhaoming Zhou, Ruoying Yu, Qiuxiang Ou, Xue Wu, Xiaoxia Wang, Yang Shao, Linbo Cai, Hui-qiang Huang
Journal: Blood
Blood (2020) 136 (Supplement 1): 34.
https://doi.org/10.1182/blood-2020-134804
Published: 2020
Journal Articles

Preliminary Results from a Multicenter, Single-Arm, Phase 2 Study of CS1001, an Anti-Programmed Death-Ligand 1 (PD-L1) Human Monoclonal Antibody (mAb), in Patients (pts) with Relapsed or Refractory Extranodal Natural Killer/T Cell Lymphoma (rr-ENKTL)

Hui-qiang Huang, MD PhD, Rong Tao, MD PhD, Liqun Zou, Hong Cen, MD PhD, Ye Guo, MD PhD, Yunhong Huang, MD PhD, Wenbin Qian, MD PhD, Liling Zhang, MD PhD, Hui Zhou, MD PhD, Yu Yang, MD PhD, Haiyan Yang, Dan Zhu, Teng Fang, PhD, Hangjun Dai, Yueling Wang, Jianxin Yang, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2833.
https://doi.org/10.1182/blood-2019-121865
Published: 2019
Journal Articles

Safety and Efficacy of Mitoxantrone Hydrochloride Liposome in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma and Extranodal NK/T-Cell Lymphoma: A Multicenter, Single-Arm, Open-Label, Phase 2 Clinical Trial

Hui-qiang Huang, Yunhong Huang, MD PhD, Gao Yan, Haiyan Yang, Qingyuan Zhang, Runxiang Yang, Min Zhou, PhD, Yufu Li, Yan Li, Lihong Liu, Hui Zhou, MD PhD, Hongmei Jing, Zhigang Peng, MD, Ding Yu, Rong yan Zhang, Bing Xu, Xiaohong Zhang, Junyuan Qi, Liping MA, MD, Shan Chen, Jianfei Xue
Journal: Blood
Blood (2019) 134 (Supplement_1): 2838.
https://doi.org/10.1182/blood-2019-126481
Published: 2019
Journal Articles

Clinical Outcome of an Multicentre, Randomized, Phase II Clinical Trial for Patients with Extranodal NK/T Cell Lymphoma Treated By P-Gemox or Aspametdex

Hui-qiang Huang, Gao Yan, Hang Su, Yunhong Huang, Yuhuan Gao, Wang Xiaoxiao, Bai Bing, Yujing Zhang, Liping Su, Xiaoxia Chu, Wenyu Li, MD PhD, Junyi Zhang, Qiaohua Zhang, MD, Liansheng Zhang, Xiaohua Hu, Liqun Zou, Zhiming Li, Wenqi Jiang
Journal: Blood
Blood (2019) 134 (Supplement_1): 1569.
https://doi.org/10.1182/blood-2019-123478
Published: 2019
Journal Articles

Daratumumab Monotherapy for Patients with Relapsed or Refractory (R/R) Natural Killer/T-Cell Lymphoma (NKTCL), Nasal Type: Updated Results from an Open-Label, Single-Arm, Multicenter Phase 2 Study

Hui-qiang Huang, Won-Seog Kim, MD PhD, Ming Yao, MD, Tae Min Kim, MD PhD, DocHyun Yoon, MD PhD, Seok-Goo Cho, MD PhD, Hyeon-Seok Eom, MD PhD, Su-Peng Yeh, MD, Soon Thye Lim, MBBS, MRCP, FAMS, Yuqin Song, Shizhou Liu, MD, Grace Gao, Lijia Zhang, Min Qing, Ming Qi, MD PhD, Jin Seok Kim, MD PhD, Yok Lam Kwong, MD FRCP, Jie Jin, MD PhD, Yuankai Shi, MD PhD, Jun Zhu, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1568.
https://doi.org/10.1182/blood-2019-123446
Published: 2019
Journal Articles

Thalidomide Maintenance in Patients with Diffuse Large B-Cell Lymphoma after Autologous Stem Cell Transplantation: Single-Center Experience

Hui-qiang Huang, MD PhD, Bai Bing, Wang Xiaoxiao, Gao Yan, Pengfei Li, Rong Qixiang, Li-qin Ping
Journal: Blood
Blood (2018) 132 (Supplement 1): 1714.
https://doi.org/10.1182/blood-2018-99-111819
Published: 2018
Journal Articles

P-Gemox Regimen(Pegaspargase, Gemcitabine, oxaliplatin) for Extranodal Natural Killer Cell Lymphoma: 10 Years' Real-World Clinical Experience from China

Gao Yan, Hui-qiang Huang, MD PhD, Wang Xiaoxiao, Bai Bing, Pengfei Li, Hui Zhou, Zhi-gang Peng, Xiao-yan Ke, Kai-yang Ding, Yu Yang, MD, Sha-dong Min, Yue-rong Shuang, Li Zhiming, Cai Qingqing, Bingzong Li, MDPhD, Wenqi Jiang
Journal: Blood
Blood (2018)
https://doi.org/10.1182/blood-2018-99-116551
Published: 2018
Journal Articles

The Therapeutic Response of Chidamide Was Associated with Elevated H3 Acetylation Level in Patients with Refractory/Relapsed Non-Hodgkin Lymphoma (R/R-NHL)

Hui-qiang Huang, MD PhD, Pengfei Li, Yan Gao, Bai Bing, Wang Xiaoxiao, Rong Qixiang, Su Li, Wenqi Jiang
Journal: Blood
Blood (2017) 130 (Supplement 1): 4080.
https://doi.org/10.1182/blood.V130.Suppl_1.4080.4080
Published: 2017
Journal Articles

Chidamide ,Oral Subtype-Selective Histone Deacetylase Inhibitor (HDACI) Monotherapy Was Effective on the Patients with Relapsed or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma

Gao Yan, Hui-qiang Huang, Pengfei Li, Bai Bing, Wang Xiaoxiao, Rong Qixiang, Li Zhiming, Cai Qingqing, Wenqi Jiang
Journal: Blood
Blood (2017) 130 (Supplement 1): 2797.
https://doi.org/10.1182/blood.V130.Suppl_1.2797.2797
Published: 2017
Journal Articles

Open-Label Study of Bendamustine Hydrochloride in Chinese Patients with Indolent Non-Hodgkin Lymphoma (NHL) Refractory to Rituximab Treatment

Yuan-Kai Shi, Xiao Nan Hong, Hui Qiang Huang, Wei Xu, Ling Chen, Udo Mueller
Journal: Blood
Blood (2016) 128 (22): 5340.
https://doi.org/10.1182/blood.V128.22.5340.5340
Published: 2016
Journal Articles

The Activation Of M2 Polarized Tumor-Associated Macrophages In The Microenvironment Of NK/T-Cell Lymphoma and The Characteristics Of Cytokine Spectrum

Bing Bai, M.D., Ph.D., Hui-qiang Huang, M.D., Ph.D., Qi-chun Cai, M.D., Ph.D., Xiao-Xiao Wang, M.D, Ph.D., Qingqing Cai, M.D, Ph.D., Yan Gao, M.D., Wei Zhao, M.D.
Journal: Blood
Blood (2013) 122 (21): 4274.
https://doi.org/10.1182/blood.V122.21.4274.4274
Published: 2013
Journal Articles

Novel Combination Of Lenalidomide-Rituximab Provides An Effective Bridge To Stem Cell Transplantation In Relapsed and/Or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphomas: A Single Center Experience

Qingqing Cai, MD, PhD, Yiming Chen, MD., PhD., Dehui Zou, Maria Badillo, BS, Shouhao Zhou, PhD, Liang Zhang, MD, PhD, Elyse R Lopez, Wenqi Jiang, MD, PhD, Hui-qiang Huang, MD, PhD, Tongyu Lin, MD, PhD, Michael Wang, MD
Journal: Blood
Blood (2013) 122 (21): 3056.
https://doi.org/10.1182/blood.V122.21.3056.3056
Published: 2013
Journal Articles

IL-6 Promotes Cell Proliferation and Antiapoptosis Through Activation Of The JAK/STAT3 Pathway In Patients With NK/T - Cell Lymphoma and Correlates With Poor Treatmemt Outcome

Qichun Cai, M.D., Ph.D., Hui-qiang Huang, MD, PhD, Bing Bai, M.D., Ph.D., Suxia Lin, M.D., Ph.D., Yan Gao, M.D., Yi Xia, M.D., Ph.D., XiaoXiao Wang, M.D., Ph.D., Jiabin Lu
Journal: Blood
Blood (2013) 122 (21): 1758.
https://doi.org/10.1182/blood.V122.21.1758.1758
Published: 2013
Journal Articles

The Serum Spectrum Of Cytokines In Patients With NK/T-Cell Lymphoma and Its Cilincial Significance In Survival

Qichun Cai, M.D., Ph.D., Hui-qiang Huang, M.D., Ph.D., Bing Bai, M.D., Ph.D., Gao Yan, M.D., Jiang Li, M.D., Ph.D., Suxia Lin, M.D., Ph.D., Yi Xia, M.D., Ph.D., Xiaoxiao Wang, M.D., Ph.D., Jiabin Lu
Journal: Blood
Blood (2013) 122 (21): 1759.
https://doi.org/10.1182/blood.V122.21.1759.1759
Published: 2013
Journal Articles

The Prognostic Value Of Dynamic Monitoring C-Reactive Protein (CRP) Serum Levels In NK/T-Cell Lymphoma

Bing Bai, M.D., Ph.D., Hui-qiang Huang, M.D., Ph.D., Qi-chun Cai, M.D., Ph.D., Xiao-Xiao Wang, M.D, Ph.D., Qingqing Cai, M.D, Ph.D., Yan Gao, M.D., Wei Zhao, M.D.
Journal: Blood
Blood (2013) 122 (21): 1760.
https://doi.org/10.1182/blood.V122.21.1760.1760
Published: 2013